Low-dose aspirin can benefit a small subset of pregnant women to prevent the potentially life-threatening complication called pre-eclampsia, said US health authorities on Tuesday.
Low-dose aspirin can benefit a small subset of pregnant women to prevent the potentially life-threatening complication called pre-eclampsia, said US health authorities on Tuesday. Women with diabetes, chronic hypertension, those carrying multiple fetuses or who have a history of pre-eclampsia in prior pregnancies could benefit from starting a regimen of low-dose aspirin after their first trimester, said the US Preventive Services Task Force.
"Low-dose aspirin (range, 50 to 160 mg/day) reduced the risk for pre-eclampsia by 24 percent in clinical trials," said a USPTF statement.
Daily low-dose aspirin "also reduced the risk for preterm birth by 14 percent" and cut the risk by 20 percent of a complication that makes delays babies' growth.
The use of low dose aspirin appeared to cause no short-term harm in 19 randomized controlled trials analyzed.
The recommendations only apply to women at high risk of pre-eclampsia, a condition which affects between two and eight percent of pregnancies worldwide.
Pre-eclampsia is blamed for about 15 percent of all preterm births, and can be fatal to the mother and child.
Advertisement
The recommendations were published in the Annals of Internal Medicine.
Advertisement